CGON vs. ARTV
CGON (CG Oncology, Inc) and ARTV (Artiva Biotherapeutics, Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past year, CGON returned 156.16% vs 504.94% for ARTV. At a 0.34 correlation, their price movements are largely independent.
Performance
CGON vs. ARTV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CGON achieves a 58.31% return, which is significantly lower than ARTV's 128.44% return.
CGON
- 1D
- -0.78%
- 1M
- 2.30%
- YTD
- 58.31%
- 6M
- 64.12%
- 1Y
- 156.16%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ARTV
- 1D
- 4.70%
- 1M
- 24.52%
- YTD
- 128.44%
- 6M
- 129.51%
- 1Y
- 504.94%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CGON vs. ARTV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
CGON CG Oncology, Inc | 58.31% | 44.77% | -21.90% |
ARTV Artiva Biotherapeutics, Inc | 128.44% | -57.44% | -37.00% |
Correlation
The correlation between CGON and ARTV is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.33 |
Correlation (All Time) Calculated using the full available price history since Jul 19, 2024 | 0.34 |
Fundamentals
CGON:
$5.56B
ARTV:
$241.85M
CGON:
-$1.61
ARTV:
-$3.55
CGON:
5.09
ARTV:
2.75
CGON:
$5.07M
ARTV:
$0.00
CGON:
-$2.54M
ARTV:
$0.00
CGON:
-$191.51M
ARTV:
-$90.10M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CGON vs. ARTV — Risk / Return Rank
CGON
ARTV
CGON vs. ARTV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CG Oncology, Inc (CGON) and Artiva Biotherapeutics, Inc (ARTV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CGON | ARTV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.02 | ||
| Sortino ratioReturn per unit of downside risk | -0.55 | ||
| Omega ratioGain probability vs. loss probability | 1.41 | 1.49 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 5.73 | 10.35 | -4.62 |
| Martin ratioReturn relative to average drawdown | 17.66 | 18.64 | -0.98 |
Loading charts...
Drawdowns
CGON vs. ARTV - Drawdown Comparison
The maximum CGON drawdown since its inception was -67.47%, smaller than the maximum ARTV drawdown of -90.81%. Use the drawdown chart below to compare losses from any high point for CGON and ARTV.
Loading charts...
Drawdown Indicators
| CGON | ARTV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.47% | -90.81% | +23.34% |
Max Drawdown (1Y)Largest decline over 1 year | -27.41% | -49.22% | +21.81% |
Current DrawdownCurrent decline from peak | -11.18% | -38.75% | +27.57% |
Average DrawdownAverage peak-to-trough decline | -25.77% | -60.58% | +34.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.88% | 27.27% | -18.39% |
Volatility
CGON vs. ARTV - Volatility Comparison
The current volatility for CG Oncology, Inc (CGON) is 16.34%, while Artiva Biotherapeutics, Inc (ARTV) has a volatility of 27.37%. This indicates that CGON experiences smaller price fluctuations and is considered to be less risky than ARTV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CGON | ARTV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.34% | 27.37% | -11.03% |
Volatility (6M)Calculated over the trailing 6-month period | 42.03% | 76.49% | -34.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 57.56% | 187.99% | -130.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.48% | 159.11% | -92.63% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 66.48% | 159.11% | -92.63% |
Dividends
CGON vs. ARTV - Dividend Comparison
Neither CGON nor ARTV has paid dividends to shareholders.
Financials
CGON vs. ARTV - Financials Comparison
This section allows you to compare key financial metrics between CG Oncology, Inc and Artiva Biotherapeutics, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CGON and ARTV have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARTV has higher volatility (27.37%) compared to CGON (16.34%). In terms of maximum drawdown, CGON dropped -67.47% vs ARTV's -90.81%.
CGON currently has the higher Sharpe Ratio (2.73 vs 2.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CGON and ARTV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer